Aramis Therapeutics

About

Aramis Therapeutics is a hybrid medical and biotech organization combining clinical neuroscience with advanced research to address neurological diagnosis, recovery, and therapeutic innovation. The organization operates clinical centers for advanced neurological rehabilitation and an advanced neuroscience research center, focusing on neuroplasticity, neuroregeneration, and autoimmune disorders with neurological involvement using AI-driven analytics and robotic-assisted systems.

Founders

• Frédéric Ors — CEO and Co-Founder
• Marc-André D’Aoust — CSO and Co-Founder
• Nicolas Petit — COO and Co-Founder

Investors

News

• Government of Canada announces investment in Québec-based Aramis Biotechnologies - Canada.ca · 2024-12-01T00:00:00.000Z
• Announcement | Aramis Biotechnologies · 2025-06-12T00:16:20.000Z
• Aramis Biotechnologies secures $80 million CAD for vaccine... · 2024-12-06T00:00:00.000Z
• Aramis secures $70M funding including $40M from Government of Canada | Private Capital Journal · 2024-12-05T18:02:13.000Z
• Announcement | Aramis Biotechnologies · 2026-02-25T16:26:23.000Z
• Aramis Biotechnologies - Unveils Breakthroughs in Plant-Based Protein Production at Inaugural Scientific Horizon Event - BIOTECanada · 2025-06-12T13:39:48.000Z

Browse related software

• Clinic software in CA
• Clinic software in Los Angeles
• All clinic software companies A–Z